Human recombinant factor IX: safety and efficacy studies in hemophilia B patients previously treated with plasma-derived factor IX concentrates

被引：3
|
作者：
Haase, M [1 ]
机构：
[1] Paul Ehrlich Inst, D-63225 Langen, Germany
来源：
BLOOD | 2002年 / 100卷 / 12期
关键词：
D O I：
10.1182/blood-2002-07-2080
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：4242 / 4242
页数：1
相关论文
共 50 条
  • [1] Human recombinant factor IX: safety and efficacy studies in hemophilia B patients previously treated with plasma-derived factor IX concentrates
    Roth, DA
    Kessler, CM
    Pasi, KJ
    Rup, B
    Courter, SG
    Tubridy, KL
    [J]. BLOOD, 2001, 98 (13) : 3600 - 3606
  • [2] Comparison of in vivo recovery of recombinant factor IX and plasma derived factor IX in previously treated Japanese hemophilia B patients
    Yamashita, A.
    Nagae, C.
    Ashikaga, T.
    Muto, S.
    Yamazaki, S.
    Takayama, S.
    Taki, M.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 577 - 578
  • [3] Viral safety of plasma-derived factor VIII and IX concentrates
    Ludlam, CA
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 1997, 8 : S19 - S23
  • [4] Pharmacokinetics of recombinant and plasma-derived factor IX products in pediatric patients with severe hemophilia B
    Nagel, K.
    Decker, K.
    Goldsmith, R.
    Chan, Anthony K.
    [J]. BLOOD COAGULATION & FIBRINOLYSIS, 2015, 26 (01) : 113 - 114
  • [5] Recombinant factor IX in the treatment of previously-treated patients with hemophilia B
    White, G
    Shapiro, A
    Lusher, J
    Roth, D
    Pasi, J
    Keutzer, T
    Courter, S
    Tubridy, K
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 609 - 609
  • [6] Recombinant factor IX in the treatment of previously-treated patients with hemophilia B
    White, G
    Pasi, KJ
    Lusher, J
    Brackmann, HH
    Magill, M
    Courter, S
    [J]. THROMBOSIS AND HAEMOSTASIS, 1997, : PS211 - PS211
  • [7] Pharmacokinetic study of recombinant human factor IX in previously treated patients with hemophilia B in Taiwan
    Chang, Hsiu-Hao
    Yang, Yung-Li
    Hung, Mei-Hua
    Tsay, Woei
    Shen, Ming-Ching
    [J]. JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2007, 106 (04) : 281 - 287
  • [8] THE HEMOSTATIC AND PHARMACOKINETIC RESPONSE OF RECOMBINANT HUMAN FACTOR-IX IS SIMILAR TO PLASMA-DERIVED HUMAN FACTOR-IX IN THE HEMOPHILIA-B DOG
    BRINKHOUS, KM
    SIGMAN, J
    READ, MS
    STEWART, P
    TIMONY, G
    MCCARTHY, K
    LEPPANEN, S
    RUP, B
    KEITH, JC
    SCHAUB, R
    [J]. THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1011 - 1011
  • [9] Evaluation of the safety and efficacy of recombinant factor IX (nonacog alfa) in minimally treated and previously treated Chinese patients with hemophilia B
    Renchi, Y.
    Zhao, Y.
    Wang, X.
    Sun, J.
    Jin, J.
    Wu, D.
    Charnigo, R.
    O'Brien, A.
    Rendo, P.
    Zhong, Z.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 356 - 356
  • [10] Phase I/II pharmacokinetics, safety, and efficacy data of recombinant human factor IX in previously treated patients with hemophilia B.
    White, G
    Shapiro, A
    Ragni, M
    Kaye, J
    Tubridy, K
    McCarthy, K
    Courter, S
    [J]. BLOOD, 1995, 86 (10) : 761 - 761
12345